News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Prognostic and Therapeutic Insights Into MIF, DDT, and CD74 in Melanoma

News

July 26, 2024
PRESS RELEASE: On July 19, 2024, a new research paper was published in Oncotarget, entitled, “Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma.” continue reading »

Prevalence and Impact of the KIT M541L Variant in Patients With Mastocytosis

News

July 24, 2024
PRESS RELEASE: On July 22, 2024, a new research paper was published in Oncotarget, entitled, “Prevalence and impact of the KIT M541L variant in patients with mastocytosis.” continue reading »

Co-analysis of Methylation Platforms for Signatures of Biological Aging in the Domestic Dog

News

July 23, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 13, entitled, “Co-analysis of methylation platforms for signatures of biological aging in the domestic dog reveals previously unexplored confounding factors.” continue reading »

Oncotarget Welcomes New Editorial Board Members

News

July 22, 2024
Oncotarget is also offering a 50% discount on publication fees until the end of the year. continue reading »

Improved Efficacy of Pembrolizumab When Combined With sEphB4-HSA in HPV-negative EphrinB2-positive HNSCC

News

July 22, 2024
PRESS RELEASE: On July 10, 2024, a new research paper was published in Oncotarget, entitled, “Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma.” continue reading »